Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Anastasiya A. Isaeva"'
Autor:
Ekaterina A. Volosnikova, Iuliia A. Merkuleva, Tatiana I. Esina, Dmitry N. Shcherbakov, Mariya B. Borgoyakova, Anastasiya A. Isaeva, Valentina S. Nesmeyanova, Natalia V. Volkova, Svetlana V. Belenkaya, Anna V. Zaykovskaya, Oleg V. Pyankov, Ekaterina V. Starostina, Alexey M. Zadorozhny, Boris N. Zaitsev, Larisa I. Karpenko, Alexander A. Ilyichev, Elena D. Danilenko
Publikováno v:
Vaccines, Vol 11, Iss 4, p 808 (2023)
Despite the rapid development and approval of several COVID vaccines based on the full-length spike protein, there is a need for safe, potent, and high-volume vaccines. Considering the predominance of the production of neutralizing antibodies targeti
Externí odkaz:
https://doaj.org/article/f1e47c9a247e478f964607cf1e5745a2
Autor:
Ekaterina D. Mordvinova, Polina A. Nikitina, Olga I. Yarovaya, Ekaterina A. Volosnikova, Denis E. Murashkin, Anastasiya A. Isaeva, Tatiana Y. Koldaeva, Valery P. Perevalov, Nariman F. Salakhutdinov, Dmitriy N. Shcherbakov
Publikováno v:
Chemosensors, Vol 11, Iss 2, p 135 (2023)
Angiotensin-converting enzyme 2 (ACE2), the functional receptor of SARS-CoV-2, plays a crucial role in the pathogenesis of COVID-19. ACE2 targeting holds the promise for preventing and inhibiting SARS-CoV-2 infection. In this work, we describe the de
Externí odkaz:
https://doaj.org/article/9e7c8c4cc3f945dfb9c9c74a84b1a036
Autor:
Iuliia A. Merkuleva, Dmitry N. Shcherbakov, Mariya B. Borgoyakova, Anastasiya A. Isaeva, Valentina S. Nesmeyanova, Natalia V. Volkova, Vazirbek S. Aripov, Daniil V. Shanshin, Larisa I. Karpenko, Svetlana V. Belenkaya, Elena I. Kazachinskaia, Ekaterina A. Volosnikova, Tatiana I. Esina, Alexandr A. Sergeev, Kseniia A. Titova, Yulia V. Konyakhina, Anna V. Zaykovskaya, Oleg V. Pyankov, Evgeniia A. Kolosova, Olesya E. Viktorina, Arseniya A. Shelemba, Andrey P. Rudometov, Alexander A. Ilyichev
Publikováno v:
Viruses, Vol 14, Iss 5, p 1060 (2022)
Currently, SARS-CoV-2 spike receptor-binding-domain (RBD)-based vaccines are considered one of the most effective weapons against COVID-19. During the first step of assessing vaccine immunogenicity, a mouse model is often used. In this paper, we test
Externí odkaz:
https://doaj.org/article/ab394414579e470699bdf6fb1e5c2212
Autor:
Iuliia A. Merkuleva, Dmitry N. Shcherbakov, Mariya B. Borgoyakova, Daniil V. Shanshin, Andrey P. Rudometov, Larisa I. Karpenko, Svetlana V. Belenkaya, Anastasiya A. Isaeva, Valentina S. Nesmeyanova, Elena I. Kazachinskaia, Ekaterina A. Volosnikova, Tatiana I. Esina, Anna V. Zaykovskaya, Oleg V. Pyankov, Sophia S. Borisevich, Arseniya A. Shelemba, Anton N. Chikaev, Alexander A. Ilyichev
Publikováno v:
Vaccines, Vol 10, Iss 1, p 96 (2022)
The receptor-binding domain (RBD) of the protein S SARS-CoV-2 is considered to be one of the appealing targets for developing a vaccine against COVID-19. The choice of an expression system is essential when developing subunit vaccines, as it ensures
Externí odkaz:
https://doaj.org/article/7d9cc82cc3cc419aa6a12cb07cd9fe91
Autor:
Vladimir Mironov, Irina A. Shchugoreva, Polina V. Artyushenko, Dmitry Morozov, Nicola Borbone, Giorgia Oliviero, Tatiana N. Zamay, Roman V. Moryachkov, Olga S. Kolovskaya, Kirill A. Lukyanenko, Yanling Song, Iuliia A. Merkuleva, Vladimir N. Zabluda, Georgy Peters, Lyudmila S. Koroleva, Dmitry V. Veprintsev, Yury E. Glazyrin, Ekaterina A. Volosnikova, Svetlana V. Belenkaya, Tatiana I. Esina, Anastasiya A. Isaeva, Valentina S. Nesmeyanova, Daniil V. Shanshin, Anna N. Berlina, Nadezhda S. Komova, Valery A. Svetlichnyi, Vladimir N. Silnikov, Dmitriy N. Shcherbakov, Galina S. Zamay, Sergey S. Zamay, Tatyana Smolyarova, Elena P. Tikhonova, Kelvin H.‐C. Chen, U‐Ser Jeng, Gerolama Condorelli, Vittorio Franciscis, Gerrit Groenhof, Chaoyong Yang, Alexander A. Moskovsky, Dmitri G. Fedorov, Felix N. Tomilin, Weihong Tan, Yuri Alexeev, Maxim V. Berezovski, Anna S. Kichkailo
Publikováno v:
Chemistry – A European Journal. 28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ecd880a84f44db1fe3d666730d8044e
https://doi.org/10.1002/chem.202200378
https://doi.org/10.1002/chem.202200378
Autor:
Vladimir Mironov, Irina A. Shchugoreva, Polina V. Artyushenko, Dmitry Morozov, Nicola Borbone, Giorgia Oliviero, Tatiana N. Zamay, Roman V. Moryachkov, Olga S. Kolovskaya, Kirill A. Lukyanenko, Yanling Song, Iuliia A. Merkuleva, Vladimir N. Zabluda, Georgy Peters, Lyudmila S. Koroleva, Dmitry V. Veprintsev, Yury E. Glazyrin, Ekaterina A. Volosnikova, Svetlana V. Belenkaya, Tatiana I. Esina, Anastasiya A. Isaeva, Valentina S. Nesmeyanova, Daniil V. Shanshin, Anna N. Berlina, Nadezhda S. Komova, Valery A. Svetlichnyi, Vladimir N. Silnikov, Dmitriy N. Shcherbakov, Galina S. Zamay, Sergey S. Zamay, Tatyana Smolyarova, Elena P. Tikhonova, Kelvin H.‐C. Chen, U‐Ser Jeng, Gerolama Condorelli, Vittorio Franciscis, Gerrit Groenhof, Chaoyong Yang, Alexander A. Moskovsky, Dmitri G. Fedorov, Felix N. Tomilin, Weihong Tan, Yuri Alexeev, Maxim V. Berezovski, Anna S. Kichkailo
Publikováno v:
Chemistry-A European journal. 2022. Vol. 28, № 12. P. e202104481 (1-16)
Chemistry, vol 28
Chemistry, vol 28
Aptamer selection against novel infections is a complicated and time-consuming approach. Synergy can be achieved by using computational methods together with experimental procedures. This study aims to develop a reliable methodology for a rational ap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6a4c66c212c1d452a13ece0e2edfec3
https://doi.org/10.1002/chem.202104481
https://doi.org/10.1002/chem.202104481
Autor:
Mariya B. Borgoyakova, Larisa I. Karpenko, Andrey P. Rudometov, Ekaterina A. Volosnikova, Iuliia A. Merkuleva, Ekaterina V. Starostina, Alexey M. Zadorozhny, Anastasiya A. Isaeva, Valentina S. Nesmeyanova, Daniil V. Shanshin, Konstantin O. Baranov, Natalya V. Volkova, Boris N. Zaitsev, Lyubov A. Orlova, Anna V. Zaykovskaya, Oleg V. Pyankov, Elena D. Danilenko, Sergei I. Bazhan, Dmitry N. Shcherbakov, Alexander V. Taranin, Alexander A. Ilyichev
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 4; Pages: 2188
Despite the fact that a range of vaccines against COVID-19 have already been created and are used for mass vaccination, the development of effective, safe, technological, and affordable vaccines continues. We have designed a vaccine that combines the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed741d81dc6147c80039e712d897b7e9
https://pubmed.ncbi.nlm.nih.gov/35216301
https://pubmed.ncbi.nlm.nih.gov/35216301
Autor:
Tat'yana N. Beschastnova, Nataliya A. Zhukova, Anastasiya O. Isaeva, Vakhid A. Mamedov, Milyausha S. Kadyrova, Elena L. Gavrilova, Oleg G. Sinyashin, Sevil V. Mamedova, Victor V. Syakaev, Shamil K. Latypov
Publikováno v:
Journal of Heterocyclic Chemistry. 56:2221-2234
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d1add59b29428c2cee2aa1124555763
https://doi.org/10.1002/jhet.3616
https://doi.org/10.1002/jhet.3616
Autor:
Evgeniia A. Kolosova, Olga N. Shaprova, Daniil V. Shanshin, Valentina S. Nesmeyanova, Iuliia A. Merkuleva, Svetlana V. Belenkaya, Anastasiya A. Isaeva, Artem O. Nikitin, Ekaterina A. Volosnikova, Yuliya A. Nikulina, Marina A. Nikonorova, Dmitry N. Shcherbakov, Svetlana A. Elchaninova
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 14; Pages: 4053
Identification of factors behind the level and duration of persistence of the SARS-CoV-2 antibodies in the blood is assumed to set the direction for studying humoral immunity mechanisms against COVID-19, optimizing the strategy for vaccine use, antib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5e3bd5102e29255b1ccedd89a96afd8
https://doi.org/10.3390/jcm11144053
https://doi.org/10.3390/jcm11144053
Antibodies to the Spike Protein Receptor-Binding Domain of SARS-CoV-2 at 4–13 Months after COVID-19.
Autor:
Kolosova, Evgeniia A.1,2 (AUTHOR) kurchanovaea@gmail.com, Shaprova, Olga N.1 (AUTHOR) dan6091154224@gmail.com, Shanshin, Daniil V.1,2 (AUTHOR) nesmeyanova_vs@vector.nsc.ru, Nesmeyanova, Valentina S.1 (AUTHOR) j.a.merkulyeva@gmail.com, Merkuleva, Iuliia A.1 (AUTHOR) belenkaya.sveta@gmail.com, Belenkaya, Svetlana V.1 (AUTHOR) anastasya_isaeva_1993@mail.ru, Isaeva, Anastasiya A.1 (AUTHOR) a.nikitin1@g.nsu.ru, Nikitin, Artem O.1 (AUTHOR) volosnikova_ea@vector.nsc.ru, Volosnikova, Ekaterina A.1 (AUTHOR) dnshcherbakov@gmail.com, Nikulina, Yuliya A.3 (AUTHOR) julia_didenko91@mail.ru, Nikonorova, Marina A.3 (AUTHOR) ma.nikulina@mail.ru, Shcherbakov, Dmitry N.1,2 (AUTHOR), Elchaninova, Svetlana A.4 (AUTHOR) saelch@mail.ru
Publikováno v:
Journal of Clinical Medicine. Jul2022, Vol. 11 Issue 14, p4053-4053. 14p.